Role of hormones and neurosteroids in epileptogenesis

Frontiers in Cellular Neuroscience

Volumn , Issue JUL, 2013, Pages

  Reddy, Doodipala Samba ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Epilepsy; Epileptogenesis; Estrogen; Kindling; Neurosteroid; Progesterone

Indexed keywords

11 DEOXYCORTISOL (PREGN 4 ENE 17,21 DIOL 3,20 DIONE); 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ALDOSTERONE; ANASTROZOLE; ANDROSTANOLONE; AROMATASE; BICUCULLINE; CORTICOSTEROID; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEOXYCORTICTOSTERONE; ESTRADIOL; ESTROGEN; FINASTERIDE; GLUCOCORTICOID; HYDROCORTISONE; KAINIC ACID; LETROZOLE; NEUROSTEROID; PENTETRAZOLE; PILOCARPINE; PLACEBO; PROGESTERONE; PROGESTERONE DERIVATIVE; STEROID HORMONE; TESTOLACTONE; TESTOSTERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE STRESS; ANTIEPILEPTOGENIC ACTIVITY; ARTICLE; BRAIN INFECTION; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CHRONIC STRESS; DISEASE EXACERBATION; DIZZINESS; DRUG ACTIVITY; DRUG EFFICACY; ELECTROENCEPHALOGRAM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; EPILEPTOGENIC ACTIVITY; FATIGUE; HUMAN; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROCONVULSANT ACTIVITY; PROTEIN BINDING; SEDATION; SEIZURE; SEX DIFFERENCE; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME;

EID: 84879754172     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00115     Document Type: Article

References (246)

1. Acharya, M.M., Hattiangady, B., and Shetty, A.K. (2008). Progress in neuroprotective strategies for preventing epilepsy. Prog Neurobiol 84,363-404.
2. Agís-Balboa, R.C., Pinna, G., Zhubi, A., Maloku, E., Veldic, M., Costa, E., and Guidotti, A. (2006). Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci USA. 103, 14602-14607.
3. Aird, R.B. (1944). The effect of desoxycorticosterone in epilepsy. J Nerv Ment Dis 99, 501-510.
4. Aird, R.B. and Gordan, G.S. (1951). Anticonvulsive properties of desoxycorticosterone. J Am Med Assn 145, 715-719.
5. Akk, G., Bracamontes, J., and Steinbach, J.H. (2001). Pregnenolone sulfate block of GABAA receptors: mechanism and involvement of a residue in the M2 region of the eesubunit. J Physiol (Lond) 532, 673-684.
6. Arida, R.M., de Jesus Vieira, A., and Cavalheiro, E.A. (1998). Effect of physical exercise on kindling development. Epilepsy Res 30,127-132.
7. Arida, R.M., Scorza, F.A., and Cavalheiro, E.A. (2010). Favorable effects of physical activity for recovery in temporal lobe epilepsy. Epilepsia 51(Suppl 3),76-9.
8. Arida, R.M., Scorza, F.A., de Lacerda, A.F., Gomes da Silva, S., and Cavalheiro, E.A. (2007). Physical training in developing rats does not influence the kindling development in the adult life. Physiol Behav 90,629-633.
9. Arida, R.M., Scorza, F.A., dos Santos, N.F., Peres, C.A., and Cavalheiro, E.A. (1999). Effect of physical exercise on seizure occurrence in a model of temporal lobe epilepsy in rats. Epilepsy Res 37,45-52.
10. Austin, J.K., Hesdorffer, D.C., Liverman, C.T., and Schultz, A. M; Testimony Group (2012). Testimonies submitted for the Institute of Medicine report: epilepsy across the spectrum: promoting health and understanding. Epilepsy Behav 25,634-661.
11. Auvergne, R., Leré, C., El Bahh, B., Arthaud, S., Lespinet, V., Rougier, A., and Le Gal La Salle, G. (2002). Delayed kindling epileptogenesis and increased neurogenesis in adult rats housed in an enriched environment. Brain Res 954,277-285.
12. Bäckström, T. (1976). Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 54,321-347.
13. Bäckström, T., Zetterlund, B., Blom, S., and Romano, M (1984). Effect of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol. Scand 69, 240-248.
14. Barbaccia, M.L., Roscetti, G., Trabucchi, M., Mostallino, M.C., Concas, A., Purdy, R.H., and Biggio, G. (1996). Time-dependent changes in rat brain neuroactive steroid concentrations and GABA-A receptor function after acute stress. Neuroendocrinology 63, 166-172.
15. Barbaccia, M.L., Roscetti, G., Trabucchi, M., Purdy, R.H., Mostallino, M.C., Concas, A., and Biggio, G. (1997). The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol. 120, 1582-1588.
16. Bauer, J., Stoffel-Wagner, B., Flügel, D., Kluge, M., Schramm, J., Bidlingmaier, F., and Elger, C.E. (2000). Serum androgens return to normal after temporal lobe epilepsy surgery in men. Neurology. 55, 820-824.
17. Belelli, D., Bolger, M.B., and Gee, K.W. (1989). Anticonvulsant profile of the progesterone metabolite 55-pregnan-3--ol-20-one. Eur J Pharmacol. 166, 325-329.
18. Belelli, D., Casula, A., Ling, A., and Lambert, J.J. (2002). The influence of subunit composition on the interaction of neurosteroids with GABAA receptors. Neuropharmacology 43, 651-661.
19. Belelli, D., Bolger, M.B., and Gee, K.W. (1989). Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur J Pharmacol 166, 325-329.
20. Biagini, G., Baldelli, E., Longo, D., Pradelli, L., Zini, I., Rogawski, M.A., and Avoli, M. (2006). Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp Neurol 201, 519-524.
21. Biagini, G., Longo, D., Baldelli, E., Zoli, M., Rogawski, M.A., Bertazzoni, G., and Avoli, M. (2009). Neurosteroids and epileptogenesis in the pilocarpine model: Evidence for a relationship between P450scc induction and length of the latent period. Epilepsia 50(Suppl 1), 53-58.
22. Biagini, G., Baldelli, E., Longo, D., Pradelli, L., Zini, I., Rogawski, M.A., and Avoli, M (2006). Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp Neurol 201, 519-524.
23. Biagini, G., Panuccio, G., and Avoli, M. (2010). Neurosteroids and epilepsy. Curr Opin Neurol. 23, 170-176.
24. Bianchi, M.T., and Macdonald, RL (2003). Neurosteroids shift partial agonist activation of GABA-A receptor channels from low-to high-efficacy gating patterns. J Neurosci 23(34):10934-10943.
25. Bonuccelli, U., Melis, G.B., Paoletti, A.M., Fioretti, P., Murri, L., Muratorio, A (1989). Unbalanced progesterone and estradiol secretion in catamenial epilepsy. Epilepsy Res. 3, 100-106.
26. Borekci, B., Ingec, M., Yilmaz, M., Kukula, O., Karaca, M., Hacimuftuoglu, A., Halici, Z., and Suleyman, H. (2010). Effects of female sex hormones on caffeine-induced epileptiform activity in rats. Gynecol Endocrinol. 26:366-371.
27. Brinton, R.D., Thompson, R.F., Foy, M.R., Baudry, M., Wang, J., Finch, C.E., Morgan, T.E., Pike, C.J., Mack, W.J., Stanczyk, F.Z., and Nilsen, J (2008). Progesterone receptors: form and function in brain. Front Neuroendocrinol 29, 313-339.
28. Buckmaster, P.S., and Dudek, F.E. (1997). Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J Comp Neurol 385, 385-404.
29. Buckmaster, P.S., Zhang, G.F., and Yamawaki, R. (2002). Axon sprouting in a model of temporal lobe epilepsy creates a predominantly excitatory feedback circuit. J Neurosci 22, 6650-6658.
30. Buterbaugh, G.G. (1989). Estradiol replacement facilitates the acquisition of seizures kindled from the anterior neocortex in female rats. Epilepsy Res 4:207-215.
31. Carter, R.B., Wood, P.L., Wieland, S., Hawkinson, J.E., Belelli, D., Lambert, J.J., White, H.S., Wolf, H.H., Mirsadeghi, S., Tahir, S.H., Bolger, M.B., Lan, N.C., Gee, K.W. (1997). Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3a-hydroxy-3--methyl-5--pregnan-20-one), a selective, high-affinity, steroid modulator of the s-aminobutyric acidA receptor. Journal of Pharmacology and Experimental Therapeutics 280, 1284-1295.
32. Chisari M., Eisenman L.N., Covey D.F., Mennerick S., and Zorumski CF (2010). The sticky issue of neurosteroids and GABAA receptors. Trends Neurosci. 33, 299-306.
33. Chisari, M., Eisenman L.N., Krishnan K., Bandyopadhyaya A.K., Wang C., Taylor A., Benz A, Covey DF, Zorumski CF, and Mennerick, S. (2009). The influence of neuroactive steroid lipophilicity on GABA-A receptor modulation: evidence for a low-affinity interaction. J Neurophysiol. 102, 1254-1264.
34. Christensen, J., Kjeldsen, M.J., Anderson, H., Friis, M.L., and Sidenious, P (2005). Gender differences in epilepsy. Epilepsia 46, 956-960.
35. Citraro, R., Russo, E., Di Paola, E.D., Ibbadu, G.F., Gratteri, S., Marra, R., and De Sarro, G. (2006). Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology 50, 1059-1071.
36. Clarke, R.S., Dundee, J.W., and Carson, IW (1973). Proceedings: A new steroid anaesthetic-althesin. Proc R Soc Med. 66, 1027-1030.
37. Craig, C.R. (1966). Anticonvulsant activity of steroids: separability of anticonvulsant from hormonal effects. J. Pharmacol. Exp. Ther. 153, 337-343.
38. Cutler, S.M., Cekic, M., Miller, D.M., Wali, B., VanLandingham, J.W., and Stein, DG (2007). Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma 24,1475-86.
39. Cutler, S.M., Pettus, E.H., Hoffman, S.W., and Stein, DG (2005). Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury. Exp Neurol 195, 423-9.
40. de Araujo Furtado, M., Rossetti, F., Chanda, S., and Yourick, D. (2012). Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy. Neurotoxicology 33,1476-1490.
41. DeCoster, M., Lambeau, G., Lazdunski, M., and Bazan, N.G. (2002). Secreted phospholiase A2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures. J Neurosci Res 67, 634-645.
42. Desgent, S., Duss, S., Sanon, N. T, Lema, P., Lévesque, M., Hébert, D., Rébillard, R.M., Bibeau, K., Brochu, M., and Carmant, L. (2012). Early-life stress is associated with gender-based vulnerability to epileptogenesis in rat pups. PLoS One 7(8), e42622.
43. Devaud, L.L., Purdy, R.H., Finn, D.A., and Morrow, A.L. (1996). Sensitization of z-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal. J Pharmacol Exp Ther 278,510-517.
44. Do Rego, J.L., Seong, J.Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M.C., Pelletier, G., and Vaudry, H. (2009). Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front Neuroendocrinol. 30, 259-301.
45. Dudek, F.E. and Staley, K.J. (2011). The time course of acquired epilepsy: implications for therapeutic intervention to suppress epileptogenesis. Neurosci Lett 497, 240-246.
46. Dworetzky, B.A., Townsend, M.K., Pennell, P.B., and Kang, J.H. (2012). Female reproductive factors and risk of seizure or epilepsy: data from the Nurses' Health Study II. Epilepsia 53,1-4.
47. Edwards, H.E., Mo, V., Burnham, W.M., and MacLusky, N.J. (2001). Gonadectomy unmasks an inhibitory effect of progesterone on amygdala kindling in male rats. Brain Res. 889, 260-263.
48. Edwards, H.E., Burnham, W.M. and MacLusky, N.J. (1999). Testosterone and its metabolites affect afterdischarge thresholds and the development of amygdala kindled seizures. Brain Res. 838,151-157.
49. Edwards, H.E., Epps, T., Carlen, P.L.J., and MacLusky, N. (2000). Progestin receptors mediate progesterone suppression of epileptiform activity in tetanized hippocampal slices in vitro. Neuroscience 101, 8951906.
50. El-Khayat, H.A., Shatla, H.M., Ali, G.K., Abdulgani, M.O., Tomoum, H.Y., and Attya, H.A. (2003). Physical and hormonal profile of male sexual development in epilepsy. Epilepsia 44, 447-52.
51. Engel, J., Pedley, T.A., Aicardy, J., and Dichter, MA (2007). Epilepsy: a comprehensive textbook. 2nd ed. Lippincott: Williams & Wilkins.
52. Fisher RS, van Emde Boas, W., Blume, W., Elger, C., Genton, P., Lee, P., and Engel Jr., J. (2005). Epileptic seizures and epilepsy: Definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE). Epilepsia 46, 470-472.
53. Frucht, M.M., Quigg, M., Schwaner, C., and Fountain, N.B. (2000). Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 41, 1534-1539.
54. Frye, C.A. (1995). The neuroactive steroid 3F,5,-THP has anti-seizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696, 113-120.
55. Frye, C.A. and Reed, T.A. (1998). Androgenic neurosteroids: anti-seizure effects in an animal model of epilepsy. Psychoneuroendocrinology 23, 385-399.
56. Frye CA, Rhodes ME, Walf AA, and Harney JP (2001a) Testosterone reduces pentylenetetrazoleinduced ictal activity of wildtype mice but not those deficient in type I 5i-reductase. Brain Res. 918,182-6.
57. Frye CA, Park D, Tanaka M, Rosellini R, and Svare B (2001b). The testosterone metabolite and neurosteroid 3n-androstanediol may mediate the effects of testosterone on conditioned place preference. Psychoneuroendocrinology 26, 731-750.
58. Frye, C.A., Rhodes, M.E., Walf, A., and Harney, J. (2002). Progesterone reduces pentylenetetrazolinduced ictal activity of wild-type mice but not those deficient in type I 5α-reductase. Epilepsia 43 (Suppl 5), 14-17.
59. Frye, C.A. and Scalise, T.J. (2000). Anti-seizure effects of progesterone and 3α,5α-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 25, 407-420.
60. Gangisetty, O. and Reddy, D.S. (2010). Neurosteroid withdrawal regulates GABA-A receptor α4-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway. Neuroscience 170, 865-880.
61. Gee, K. W, Bolger, M. B, Brinton, R. E, Coirini, H., and McEwen, B.S. (1988). Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther 246, 803-812.
62. Gibson, C.L., Gray, L.J., Bath, P.M., and Murphy, S.P. (2008). Progesterone for the treatment of experimental brain injury; a systematic review. Brain 131, 318-328.
63. Glauser, T., Ben-Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C., Kalviainen, R., Mattson, R., Perucca, E., Tomson, T. (2006). ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47, 1094-1120.
64. Glauser, T., Ben-Menachem, E., Bourgeois, B., Cnaan, A., Guerreiro, C., Kälviäinen, R., Mattson, R., French, J.A., Perucca, E., Tomson, T; ILAE Subcommission on AED Guidelines (2013). Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 54, 551-563.
65. Glien, M., Brandt, C., Potschka, H., Voigt, H., Ebert, U., and Löscher, W. (2001). Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy. Epilepsy Res 46, 11-119.
66. Goddard, G.V., McIntyre, D.C., and Leech, C.K. (1969). A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25, 2952330.
67. Gowers, W.R. (1881). Epilepsy and Other Chronic Convulsive Diseases. London, Churchill.
68. Grigorian, V.Z., and Khudaverkian, D.N. (1970). Effect of castration and subsequent administration of testosterone propionate on susceptibility to convulsions in animals. Zh Eksp Klin Med 10, 11-17.
69. Gyermek, L., Genther, G., Fleming, N. (1967). Some effects of progesterone and related steroids on the central nervous system. Int J Neuropharmacol 6, 191-198.
70. Harden, C. and MacLusky, N.J. (2004). Aromatase inhibition, testosterone, and seizures. Epilepsy Behav 5, 260-263.
71. Harden, C. and MacLusky, N.J. (2005). Aromatase inhibitors as add-on treatment for men with epilepsy. Expert Rev Neurother 5,123-127.
72. Harrison, N.L., Majewska, M.D., Harrington, J.W., and Barker, J.L. (1987). Structure-activity relationships for steroid interactions with the r-aminobutyric acidA receptor complex. J Pharmacol Exp Ther 241, 346-353.
73. Harrison, N.L., and Simmonds, M.A. (1984). Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 323, 287-292.
74. Hauser, W.A., Annegers, J.F., and Kurland, L.T. (1993). Incidence of epilepsy and unprovoked seizures in Rochester Minnesota during 1935-1984. Epilepsia 34, 453-468.
75. Hauser, W.A. (1997). Incidence and prevalence. In, Engel J, Jr., Pedley TA (Eds.), Epilepsy, A Comprehensive Textbook. Lippincott-Raven Publishers, Philadelphia, pp.47-57.
76. He, X-P., Kotloski, R., Nef, S., Luikart, B.W., Parada, L.F., and McNamara, J.O. (2004). Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model. Neuron 43, 31442.
77. Hellier, J.L., Patrylo, P.R., Dou, P., Nett, M., Rose, G.M., and Dudek, F.E. (1999). Assessment of inhibition and epileptiform activity in the septal dentate gyrus of freely behaving rats during the first week after kainate treatment. J. Neurosci. 19,10053-10064.
78. Herzog, A.G. (2002). Altered reproductive endocrine regulation in men with epilepsy: implications for reproductive function and seizures. Ann Neurol. 51, 539-542.
79. Herzog, A.G. and Frye, C.A. (2003). Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol 53, 390-391.
80. Herzog, A.G. (1991). Reproductive endocrine considerations and hormonal therapy for men with epilepsy. Epilepsia 32 (Suppl 6), S34-S37.
81. Herzog, A.G., Fowler, K.M., Smithson, S.D., Kalayjian, L.A., Heck, C.N., Sperling, M.R., Liporace, J.D., Harden, C.L., Dworetzky, B.A., Pennell, P.B., and Massaro, J.M.; Progesterone Trial Study Group (2012). Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial. Neurology 78, 1959-1966.
82. Herzog, A.G., Klein, P. and Jacobs, A.R. (1998). Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology 50,782-784.
83. Herzog, A.G. (1995). Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 45,1600-1662.
84. Herzog, A.G. (1999). Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 52, 1917-1918.
85. Herzog, A.G., Klein, P., and Ransil, B. J (1997). Three patterns of catamenial epilepsy. Epilepsia 38, 1082-1088.
86. Hesdorffer, D.C., Beck, V., Begley, C.E., Bishop, M.L., Cushner-Weinstein, S., Holmes, G.L., Shafer, P.O., Sirven, J.I., and Austin, J.K. (2013). Research implications of the Institute of Medicine Report, Epilepsy Across the Spectrum: Promoting Health and Understanding. Epilepsia 54, 207-216.
87. Heuser, G. and Eidelberg, E. (1961). Steroid-induced convulsions in experimental animals. Endocrinology 69, 915-924.
88. Holmes, G.L., and Weber, D.A. (1984). The effect of progesterone on kindling: a developmental study. Brain Res 318, 45353.
89. Hom, A.C., and Buterbaugh, G.G. (1986). Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats. Epilepsia 27, 103-108.
90. Hosie, A.D., Wilkins, M.E., da Silva, H.M.A., and Smart, T.G. (2006). Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444, 486-489.
91. Hosie, A.M., Clarke, L., da Silva, H, and Smart, T.G. (2009). Conserved site for neurosteroid modulation of GABAA receptors. Neuropharmacology 56, 149-154.
92. Hosie, A.M., Wilkins, M.E., and Smart, T.G. (2007). Neurosteroid binding sites on GABA-A receptors. Pharmacol Ther 116, 7-19.
93. Isojarvi, J.I., Pakarinen, A.J., and Myllyla, V.V. (1988). Effects of carbamazepine therapy on serum sex hormone levels in male patients with epilepsy. Epilepsia 29,781-786.
94. Jacobs, M.P., Fischbach, G.D., Davis, M.R., Dichter, M.A., Dingledine, R., Lowenstein, D.H., Morrell, M.J., Noebels, J.L., Rogawski, M.A., Spencer, S.S., and Theodore, W.H. (2001). Future directions for epilepsy research. Neurology 57,1536-42.
95. Jacobs, M.P., Leblanc, G.G., Brooks-Kayal, A., Jensen, F.E., Lowenstein, D.H., Noebels, J.L., Spencer, D.D., and Swann, J.W. (2009) Curing epilepsy: progress and future directions. Epilepsy Behav 14, 4384445.
96. Jacono, J.J. and Robinson, J. (1987). The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle in epileptic women. Epilepsia 28, 571-577.
97. Jiang, N., Chopp, M., Stein, D. and Feit, H. (1996). Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 735, 101-107.
98. Jöels, M. (1997). Steroid hormones and excitability in the mammalian brain. Front. Neuroendocrinol 18, 2-48.
99. Joëls, M. (2009). Stress, the hippocampus, and epilepsy. Epilepsia 50, 586-597.
100. Jones, N.C., Lee, H.E., Yang, M., Rees, S.M., Morris, M.J., O'Brien, T.J., and Salzberg, M.R. (2013). Repeatedly stressed rats have enhanced vulnerability to amygdala kindling epileptogenesis. Psychoneuroendocrinology 38, 263-270.
101. Kaminski, R.M., Fu, Z., Venkatesan, K., Mazzuferi, M., Leclercq, K., Seutin, V., and Vicini, S. (2011). 11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice. Neuropharmacology 60, 1098-1108.
102. Kaminski, R.M., Livingood, M.R., and Rogawski, M.A. (2004). Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia 45, 864-877.
103. Kaminski, R.M., Marini, H., Kim, W.J., and Rogawski, M.A. (2005). Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia 46, 819-827.
104. Kaminski, R.M., Livingood, M.R., and Rogawski, M.A. (2004). Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia 45, 864-867.
105. Karst, H., de Kloet, E.R., and Joëls, M. (1999). Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long-term changes in hippocampal CA1 cells, in the fully kindled state. Eur J Neurosci 11, 889-898.
106. Koenig, H., Schumacher, M., Ferzaz, B., Do Thi, A.N., Ressouches, A., Guennoun, R., Jung-Testas, I., Robel, P., Akwa, Y., and Baulieu, E. E (1995). Progesterone synthesis and myelin formation by Schwann cells. Science 268, 1500-1503.
107. Köhling, R. and Staley, K. (2011). Network mechanisms for fast ripple activity in epileptic tissue. Epilepsy Res 97, 318-323.
108. Kokate, T.G., Svensson, B.E., and Rogawski, MA (1994). Anticonvulsant activity of neuroactive steroids: correlation with c-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther. 270, 1223-1229.
109. Kokate, T.G., Yamaguchi, S., Pannell, L.K., Rajamani, U., Carroll, D.M., Grossman, A.B., and Rogawski, M.A. (1998). Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice. J Pharmacol Exp Ther. 287, 553-558.
110. Kokate, T.G., Banks, M.K., Magee, T., Yamaguchi, S., and Rogawski, M.A. (1999). Finasteride, a 5α-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther 288, 6792684.
111. Kokate, T.G., Juhng, K.N., Kirkby, R.D., Llamas, J., Yamaguchi, S., and Rogawski, M. A (1999). Convulsant actions of the neurosteroid pregnenolone sulfate in mice. Brain Res. 831, 119-124.
112. Kulkarni, S.K. and Reddy, D.S. (1995). Neurosteroids: a new class of neuromodulators. Drugs of Today 31, 433-455.
113. Kumar, G., Couper, A., O'Brien, T.J., Salzberg, M.R., Jones, N.C., Rees, S.M., and Morris, M.J. (2007). The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors. Psychoneuroendocrinology 32, 834-42.
114. Kumar, G., Jones, N.C., Morris, M.J., Rees, S., O'Brien, T.J., and Salzberg, M.R. (2011). Early life stress enhancement of limbic epileptogenesis in adult rats: mechanistic insights. PLoS One. 6(9):e24033.
115. Lai, M.C., Lui, C.C., Yang, S.N., Wang, J.Y., and Huang, L.T. (2009). Epileptogenesis is increased in rats with neonatal isolation and early-life seizure and ameliorated by MK-801: a long-term MRI and histological study. Pediatr Res 66, 441-447.
116. Lambert, J.J., Cooper, M.A., Simmons, R.D., Weir, C.J., and Belelli, D. (2009). Neurosteroids: endogenous allosteric modulators of GABA-A receptors. Psychoneuroendocrinology 34 (Suppl 1), S48-58.
117. Lawrence, C., Martin, B.S., Sun, C., Williamson, J., and Kapur, J. (2010). Endogenous neurosteroid synthesis modulates seizure frequency. Ann Neurol. 67, 689-693.
118. Lévesque, M., Bortel, A., Gotman, J., and Avoli, M. (2011). High-frequency (80-500 Hz) oscillations and epileptogenesis in temporal lobe epilepsy. Neurobiol Dis 42, 231-241.
119. Logothetis, J., Harner, R. and Morrel, F. (1959). The role of estrogens in catamenial exacerbation of epilepsy. Neurology 9, 352-360.
120. Lonsdale, D. and Burnham, W.M. (2003). The anticonvulsant effects of progesterone and 5n-dihydroprogesterone on amygdala-kindled seizures in rats. Epilepsia 44,1494-1499.
121. Löscher, W. (2002). Animal models of epilepsy for the development of antiepileptogenic and diseasemodifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50, 1055123.
122. MacLusky, N.J., Walters, M.J., Clark, A.S., and Toran-Allerand, C.D. (1994). Aromatase in the cerebral cortex, hippocampus, and mid-brain: ontogeny and developmental implications. Mol Cell Neurosci 5, 691-698.
123. Macphee, G.J., Larkin, J.G., Butler, E, Beastall, G.H., and Brodie, M.J. (1988). Circulating hormones and pituitary responsiveness in young epileptic men receiving long-term antiepileptic medication. Epilepsia 29, 468-75.
124. Majewska, M.D., Harrison, N.L., Schwartz, R.D., Barker, J.L., and Paul, S.M. (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232(4753), 1004-1007.
125. Majewska, M.D. and Schwartz, R.D. (1987). Pregnenolone sulfate: an endogenous antagonist of the,-aminobutyric acid receptor complex in brain? Brain Res 404, 355-360.
126. Majewska, M.D., Demirgoren, S, and Spivak, C.E., London, E.D. (1990). The neuroactive steroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABA-A receptor. Brain Res 526, 143-146.
127. Majewska, M. D (1992). Neuroactive steroids: endogenous bimodal modulators of the GABA-A receptor. Mechanism of action and physiological significance. Progr. Neurobiol. 38, 379-395.
128. Mani, R., Pollard, J. and Dichter, M.A. (2011). Human clinical trails in antiepileptogenesis. Neurosci Lett 497,251-256.
129. McClelland, S., Dubé, C.M., Yang, J., and Baram, T. Z (2001). Epileptogenesis after prolonged febrile seizures: mechanisms, biomarkers and therapeutic opportunities. Neurosci Lett 497,155-162.
130. McHugh, J.C. and Delanty, N. (2008). Epidemiology and classification of epilepsy, gender comparisons. Int Rev Neurobiol 83, 11-26.
131. McNamara, J.O., Morrisett, R. and Nadler, J.V. (1992). Recent advances in understanding mechanisms of the kindling model. Adv Neurol 57:5555560.
132. Meyer, R.P., Hagemeyer, C.E., Knoth, R., Kaufmann, M.R., and Volk, B. (2006). Anti-epileptic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus. J Neurochem 96,460-472.
133. Mienville, J.M. and Vicini, S. (1989). Pregnenolone sulfate antagonizes GABA-A receptor-mediated currents via a reduction of channel opening frequency. Brain Res 489:190-194.
134. Mihalek, R.M., Banerjee, P.K., Korpi, E.R., Quinlan, J.J., Firestone, L.L., Mi, Z.P., Lagenaur, C, Tretter, V., Sieghart, W., Anagnostaras, S.G., Sage, J.R., Fanselow, M.S., Guidotti, A., Spigelman, I., Li Z., DeLorey, T. M,. Olsen, R.W., and Homanics, G.E. (1999). Attenuated sensitivity to neuroactive steroids in i-aminobutyrate type A receptor--subunit knockout mice. Proc Natl Acad Sci USA 96, 12905-12910.
135. Mohammad, S., Abolhassan, A., and Pourgholami, M.H. (1998). Evaluation of the anticonvulsant profile of progesterone in male amygdala-kindled rats. Epilepsy Res 30:1953202.
136. Morimoto, K., Fahnestock, M., and Racine, R.J. (2004). Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73,1-60.
137. Mtchedlishvili Z, Bertram EH, Kapur J (2001). Diminished allopregnanolone enhancement of GABA-A receptor currents in a rat model of chronic temporal lobe epilepsy. J Physiol. 537(Pt 2), 453-465.
138. Mtchedlishvili, Z., and Kapur, J. (2003). A presynaptic action of the neurosteroid pregnenolone sulfate on GABAergic synaptic transmission. Mol. Pharmacol. 64, 857-864.
139. Murashima, Y.L. and Yoshii, M. (2010). New therapeutic approaches for epilepsies, focusing on reorganization of the GABA-A receptor subunits by neurosteroids. Epilepsia 51(Suppl 3),131-134.
140. Nadler, J.V. (2003). The recurrent mossy fiber pathway of the epileptic brain. Neurochem Res 28,1649-1658.
141. Norwood, B.A., Bumanglag, A.V., Osculati, F., Sbarbati, A., Marzola, P., Nicolato, E., Fabene, P.F., and Sloviter, R.S. (2010). Classic hippocampal sclerosis and hippocampal-onset epilepsy produced by a single "cryptic" episode of focal hippocampal excitation in awake rats. J Comp Neurol 518, 3381-3407.
142. Nothdurfter, C., Rammes, G., Baghai, T.C., Schüle, C., Schumacher, M., Papadopoulos, V., and Rupprecht, R. (2011). TSPO (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile. J Neuroendocrinol 24, 82-92.
143. O'Dell, C.M., Das, A., Wallace, G 4th, Ray, S.K. and Banik, N.L. (2012). Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets, a review. J Neurosci Res 90, 913-924.
144. Park-Chung, M., Malayev, A., Purdy, R.H., Gibbs, T.T., and Farb, D.H. (1999). Sulfated and unsulfated steroids modulate s-aminobutyric acidA receptor function through distinct sites. Brain Res 830,72-87.
145. Patel, M. (2004). Mitochondrial dysfunction and oxidative stress, cause and consequences of epileptic seizures. Free Radic Biol Med. 37, 1951-62.
146. Peng, Z., Huang, C.S., Stell, B.M., Mody, I., and Houser, C.R. (2004). Altered expression of the a subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy. J Neurosci 24, 8629-8639.
147. Pericic, D., Manev, H., and Bujas, M. (1996). Gonadal hormones and picrotoxin-induced convulsions in male and female rats. Brain Res 736,174-179.
148. Pesce, M.E., Acevedo, X., Bustamante, D., Miranda, H.E. and Pinardi, G. (2000). Progesterone and testosterone modulate the convulsant actions of pentylenetetrazol and strychnine in mice. Pharmacol Toxicol 87,116-119.
149. Pitkänen, A., and Lukasiuk, K. (2011). Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 10,173-186.
150. Pitkänen, A., Immonen, R.J., Gröhn, O.H., and Kharatishvili, I. (2009). From traumatic brain injury to posttraumatic epilepsy, what animal models tell us about the process and treatment options. Epilepsia 50 (Suppl 2),21529.
151. Pugnaghi, M., Monti, G., Biagini, G., Meletti, S. (2013). Temporal lobe epilepsy exacerbation during pharmacological inhibition of endogenous neurosteroid synthesis. BMJ Case Rep. Feb 19.
152. Purdy, R.H., Morrow, A.L., Blinn, J.R., and Paul, S.M. (1990). Synthesis, metabolism, and pharmacological activity of 3p-hydroxy steroids which potentiate GABA-receptor-mediated chlorideion uptake in rat cerebral cortical synaptoneurosomes. J Med Chem. 33, 1572-1581.
153. Purdy, R.H., Morrow, A.L., Moore, P.H. Jr, and Paul, S.M. (1991). Stress-induced elevations of P-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci USA 88,4553-4557.
154. Ramakrishnan, L., and Hess, GP (2010). Mechanism of potentiation of a dysfunctional epilepsy-linked mutated GABA-A receptor by a neurosteroid (3m,21-dihydroxy-5,-pregnan-20-one), transient kinetic investigations. Biochemistry 49,7892-7901.
155. Ramanathan, G. and Reddy, D.S. (2011). Inhibition of endogenous neurosteroids accelerates limbic epileptogenesis. Epilepsy Currents, 2(Suppl.1), Abst. 1.022.
156. Rao, M.S., Hattiangady, B., Reddy, D.S., and Shetty, A.K. (2006). Hippocampal neurodegeneration, spontaneous seizures, and mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy. J Neurosci Res 83,1088-1105.
157. Reddy, D.S. (2003a). Pharmacology of endogenous neuroactive steroids. Crit Rev Neurobiology 15, 197-234.
158. Reddy, D.S. (2003b). Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol. Sci 24, 103-106.
159. Reddy D.S. (2004a). Anticonvulsant activity of the testosterone-derived neurosteroid 3-androstanediol. Neuroreport 15, 515-518.
160. Reddy, D.S. (2004b). Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3R-androstanediol and 17a-estradiol. Neuroscience 129, 195-207.
161. Reddy, D.S. (2006). Physiological role of adrenal deoxycorticosterone-derived neuroactive steroids in stress-sensitive conditions. Neuroscience 138, 911-920.
162. Reddy, D.S. (2008). Mass spectrometric quantification and physiological-pharmacological activity of androgenic neurosteroids. Neurochem International 52, 541-553.
163. Reddy, D.S. (2009a). The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res 85, 1-30.
164. Reddy, D.S. (2009b). Steroid hormones and sex differences in seizure susceptibility. In: Encyclopedia of Basic Epilepsy Research (Editor, Philip Schwartzkroin), Vol 1. Oxford, Academic Press, 526-533.
165. Reddy, D.S. (2010). Neurosteroids, Endogenous role in the human brain and therapeutic potentials. Prog Brain Res 186, 113-137.
166. Reddy, D.S. (2011). Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy. Front Endocrinol 2,38.
167. Reddy, D.S. and Kulkarni, S.K. (1998). Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice. Eur. J. Pharmacol. 345, 55-59.
168. Reddy, D.S., Kulkarni, S.K. (2000). Development of neuroactive steroid-based novel psychotropic drugs. Progr Med Chem 37, 135-175.
169. Reddy, D.S. and Rogawski, M.A. (2000). Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J Pharmacol Exp Ther 295, 1241-1248.
170. Reddy, D.S., Kim, H.Y., and Rogawski, M.A. (2001). Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 42, 328-336.
171. Reddy, D.S. and Rogawski, M.A. (2001). Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 42, 303-310.
172. Reddy, D.S., and Rogawski, M.A. (2002). Stress-induced deoxycorticosterone-derived neuroactive steroids modulates GABAA receptor function and seizure susceptibility. J Neurosci. 42, 3795-3805.
173. Reddy, D.S., Castaneda, D.C., O'Malley, B.W., and Rogawski, MA (2004). Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J Pharmacol Exp Ther 310, 230-239.
174. Reddy, D.S., O'Malley, B.W. and Rogawski, M.A. (2005). Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 48, 14-24.
175. Reddy, D.S., and Rogawski, M.A. (2009). Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics. 6, 392-401.
176. Reddy, D.S., Gangisetty, O., and Briyal, S. (2010). Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis. Neuropharmacology 59, 573-581.
177. Reddy, D.S. and Jian, K. (2010). The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABA-A receptors. J Pharmacol Exp Ther 334, 1031-1041.
178. Reddy, D.S., and Rogawski, M.A. (2010). Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res. 89, 254-260.
179. Reddy, D.S., and Mohan, A. (2011). Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors. J Neurosci. 31,650-658.
180. Reddy, D.S. and Ramanathan, G. (2012). Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis. Epilepsy Behav 25, 92-97.
181. Reddy, D.S., Gould, J., Gangisetty, O. (2012). A mouse kindling model of perimenstrual catamenial epilepsy. J Pharmacol Exp Ther 341, 784-793.
182. Reddy, D.S. (2013). Neuroendocrine aspects of catamenial epilepsy. Horm Behav 63,254-266.
183. Reddy D.S., Woodward R. (2004). Ganaxolone: a prospective overview. Drugs Future 29, 227-242.
184. Reibel, S., André, V., Chassagnon, S., André, G., Marescaux, C., Nehlig, A., and Depaulis, A (2000). Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat. Neurosci. Lett. 281, 79-82.
185. Roberts, A.J. and Keith, L.D. (1995). Corticosteroids enhance convulsion susceptibility via central mineralocorticoid receptors. Psychoneuroendocrinology 20,891-902.
186. Robertson, C.R., Flynn, S.P., White, H.S., and Bulaj, G. (2011). Anticonvulsant neuropeptides as drug leads for neurological diseases. Nat Prod Rep 28,741-762.
187. Roof, R.L. and Hall, E.D. (2000). Gender differences in acute CNS trauma and stroke, neuroprotective effects of estrogen and progesterone. J. Neurotrauma. 17, 367-388.
188. Roof, R.L., Duvdevani, R., Braswell, L., and Stein DG (1994). Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 129, 64-69.
189. Roof, R.L., Hall, E. D (2000). Gender differences in acute CNS trauma and stroke, neuroprotective effects of estrogen and progesterone. J. Neurotrauma 17, 367-388.
190. Rose, R.P., Morell, F., and Hoeppner, T.J. (1979). Influences of pituitary-adrenal hormones on kindling. Brain Res. 169,303-315.
191. Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T.C., Fan, J., Akula, N., Groyer, G., Adams, D., and Schumacher, M. (2010). Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 9(12), 971-88.
192. Rupprecht, R., Rammes, G., Eser, D., Baghai, T.C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H.O., Chaperon, F., Uzunov, V., McAllister, K.H., Bertaina-Anglade, V., La Rochelle, C.D., Tuerck, D., Floesser, A., Kiese, B., Schumacher, M., Landgraf, R., Holsboer, F., and Kucher, K. (2009). Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325(5939), 490-493.
193. Rupprecht, R., Reul, J.M., Trapp, T., van Steensel, B., Wetzel, C., Damm, K., Zieglgansberger, W., and Holsboer, F (1993). Progesterone receptor-mediated effects of neuroactive steroids. Neuron 11, 523-530.
194. Saalmann, Y.B., Kirkcaldie, M.T., Waldron, S., and Calford, M.B. (2007). Cellular distribution of the GABA-A receptor-modulating 3α-hydroxy, 5α-reduced pregnane steroids in the adult rat brain. J Neuroendocrinol. 19, 272-284.
195. Salzberg, M., Kumar, G., Supit, L., Jones, N.C., Morris, M.J., Rees, S., and O'Brien, T.J. (2007). Early postnatal stress confers enduring vulnerability to limbic epileptogenesis. Epilepsia 48, 2079-2085.
196. Scharfman HE, Kim M, Hintz TM, MacLusky NJ (2008). Seizures and reproductive function, insights from female rats with epilepsy. Ann Neurol 64,687-697.
197. Scharfman, H.E., and MacLusky, N.J. (2006). The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 47,142341440.
198. Scharfman, H.E., Malthankar-Phatak, G.H., Friedman, D., Pearce, P., McCloskey, D.P., Harden, C.L., and Maclusky, N.J. (2009). A rat model of epilepsy in women: a tool to study physiological interactions between endocrine systems and seizures. Endocrinology 150,4437-4442.
199. Schwartz-Giblin, S., Korotzer, A. and Pfaff, D.W. (1989). Steroid hormone effects on picrotoxin-induced seizures in female and male rats. Brain Res 476,240-247.
200. Selye, H. (1941). Anesthetics of steroid hormones. Proc Soc Exp Biol Med 46, 116-121.
201. Selye, H. (1942). The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (metrazol). J. Lab. Clin. Med. 27, 1051-1053.
202. Shen, H., Gong, Q.H., Yuan, M., and Smith, S.S. (2005). Short-term steroid treatment increases d GABA-A receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects. Neuropharmacology 49, 573-586.
203. Shen, H., Sabaliauskas, N., Sherpa, A., Fenton, A.A., Stelzer, A., Aoki, C., and Smith SS (2010). A critical role for c4444GABA-A receptors in shaping learning deficits at puberty in mice. Science 327(5972), 1515-1518.
204. Silva de Lacerda, A.F., Janjoppi, L., Scorza, F.A., Lima, E., Amado, D., Cavalheiro, E.A., Arida, R.M. (2007). Physical exercise program reverts the effects of pinealectomy on the amygdala kindling development. Brain Res Bull 74,216-220.
205. Simonato, M., Löscher, W., Cole, A.J., Dudek, F.E., Engel, J. Jr, Kaminski, R.M., Loeb, J.A., Scharfman, H., Staley, K.J., Velíšek, L., and Klitgaard, H. (2012). Finding a better drug for epilepsy: preclinical screening strategies and experimental trial design. Epilepsia 53,1860-1867.
206. Singh, M., and Su, C. (2013). Progesterone and neuroprotection. Horm Behav 63, 284-90.
207. Sloviter, R.S. and Bumanglag, A.V. (2013). Defining "epileptogenesis" and identifying "antiepileptogenic targets" in animal models of acquired temporal lobe epilepsy is not as simple as it might seem. Neuropharmacology 69, 3-15.
208. Snead, O.C. 3rd. (1998). Ganaxolone, a selective, high-affinity steroid modulator of the G-aminobutyric acid-A receptor, exacerbates seizures in animal models of absence. Ann Neurol. 44, 688-691.
209. Spigelman, I., Li, Z., Banerjee, P.K., Mihalek, R.M., Homanics, G.E., Olsen, RW. (2002). Behavior and physiology of mice lacking the GABA-A receptor ccsubunit. Epilepsia. 43(Suppl 5), 3-8.
210. Stables, J.P., Bertram, E.H., White, H.S., Coulter, D.A., Dichter, M.A., Jacobs, M.P., Loscher, W., Lowenstein, D.H., Moshe, S.L., Noebels, J.L., and Davis, M. (2002). Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia 43,1410-20.
211. Steffensen, S.C. (1995). Dehydroepiandrosterone sulfate suppresses hippocampal recurrent inhibition and synchronizes neuronal activity to theta rhythm. Hippocampus 5,320-328.
212. Stein, D.G. and Sayeed, I. (2010). Is progesterone worth consideration as a treatment for brain injury. Am J Roentgenol 194, 20-22.
213. Stein, D.G. (2013). A clinical/translational perspective: Can a developmental hormone play a role in the treatment of traumatic brain injury? Hormone Behav 63, 291-300.
214. Stell, B.M., Brickley, S.G., Tang, C.Y., Farrant, M., and Mody, I. (2003). Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by nnsubunit-containing GABA-A receptors. Proc Natl Acad Sci USA. 100, 14439-14444
215. Stoffel-Wagner, B., Beyenburg, S., Watzka, M.S., Blumcke, I., Bauer, J., Schramm, J., Bidlingmaier, F., and Elger, C.E. (2000). Expression of 5a-reductase and 3--hydroxysteroid oxidoreductase in the hippocampus of patients with chronic temporal lobe epilepsy. Epilepsia. 41, 140-147.
216. Stoffel-Wagner, B., Watzka, M., Steckelbroeck, S., Ludwig, M., Clusmann, H., Bidlingmaier, F., Casarosa, E., Luisi, S., Elger, C.E., and Beyenburg, S. (2003). Allopregnanolone serum levels and expression of 5e-reductase and 3--hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy. Epilepsy Res. 54, 11-19.
217. Sun, C., Mtchedlishvili, Z., Erisir, A., and Kapur, J. (2007). Diminished neurosteroid sensitivity of synaptic inhibition and altered location of the a4-subunit of GABA-A receptors in an animal model of epilepsy. J Neurosci. 27, 12641-12650.
218. Sutula, T., Cascino, G., Cavazos, J., Parada, I., and Ramirez, L. (1989). Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 26,321-330.
219. Temkin, N.R., and Davis, G.R. (1984). Stress as a risk factor for seizures among adults with epilepsy. Epilepsia 25, 450-456.
220. Temkin, N. R (2001). Antiepileptogenesis and seizure prevention trials with antiepileptic drugs, metaanalysis of controlled trials. Epilepsia 42, 515-524.
221. Thomas, J. and McLean, J.H. (1991). Castration alters susceptibility of male rats to specific seizures. Physiol Behav 49,1177-1179.
222. Tsuda, M., Suzuki, T., and Misawa, M (1997). Modulation of the decrease in the seizure threshold of pentylenetetrazole in diazepam-withdrawn mice by the neuroactive steroid 5p-pregnan-3-,21-diol-20-one (alloTHDOC). Addiction Biol. 2, 455-460.
223. Twyman, R.E. and Macdonald, R.L. (1992). Neuroactive steroid regulation of GABA-A receptor singlechannel kinetic properties of mouse spinal cord neurons in culture. J Physiol. 456, 215-245.
224. Vallée, M., Rivera, J.D., Koob, G.F., Purdy, R.H., and Fitzgerald, R.L. (2000). Quantification of neuroactive steroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal Biochem 287,153-166.
225. van Vliet, E.A., Aronica, E., Tolner, E.A., Lopes da Silva, F.H., Gorter, J.A. (2004). Progression of temporal lobe epilepsy in the rat is associated with immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation. Exp Neurol 187, 367-79.
226. Velísková, J. (2006). The role of estrogens in seizures and epilepsy: the bad guys or the good guys? Neuroscience 138, 837-844.
227. Velíšková, J. (2007). Estrogens and Epilepsy: Why are we so excited? Neuroscientist 13, 77-88.
228. Velíšková, J (2009). Sex differences in seizure susceptibility. In: Encyclopedia of Basic Epilepsy Research (Editor, Philip Schwartzkroin), Oxford, Academic Press, 1-4.
229. Velísková, J. and Velísek, L. (2007). Beta-estradiol increases dentate gyrus inhibition in female rats via augmentation of hilar neuropeptide-Y. J. Neurosci. 27, 6054-6063.
230. Veliskova, J., Velisek, L., Galanopoulou, A.S., and Sperber EF (2000). Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 41(Suppl.6), S30-35.
231. Verrotti, A., Latini, G., Manco, R., De Simone, M., and Chiarelli, F. (2007). Influence of sex hormones on brain excitability and epilepsy. J Endocrinol Invest 30,797-803.
232. Vezzani, A. (2005). Inflammation and epilepsy. Epilepsy Curr 5, 1-6.
233. Vezzani, A., French, J., Bartfai, T., Baram, T.Z. (2011). The role of inflammation in epilepsy. Nat Rev Neurol 7, 31-40.
234. VMDB Report (2003). Search terms "epilepsy" in intact versus castrated dogs. The Veterinary Medical Database (www.vmdb.org).
235. Wieser, H.G., and ILAE Commission on Neurosurgery of Epilepsy (2004). ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 45, 695-714.
236. Weiss, G.K., Castillo, N., Fernandez, M. (1993). Amygdala kindling rate is altered in rats with a deficit in the responsiveness of the hypothalamo-pituitary-adrenal axis. Neurosci Lett. 157(1),91-4.
237. Wieland, S., Belluzzi, J.D., Stein, L., and Lan, N.C. (1995). Comparative behavioral characterization of the neuroactive steroids 3t-OH,5--pregnan-20-one and 3--OH,5--pregnan-20-one in rodents. Psychopharmacology. 118, 65-71.
238. Williamson, J., Mtchedlishvili, Z., and Kapur, J (2004). Characterization of the convulsant action of pregnenolone sulfate. Neuropharmacology 46, 56-864.
239. Williams, P.A., White, A.M., Clark, S., Ferraro, D.J., Swiercz, W., Staley, K.J., Dudek, F.E. (2009). Development of spontaneous recurrent seizures after kainate-induced status epilepticus. J Neurosci 29:2103-2112.
240. Wohlfarth, K.M., Bianchi, M.T., and Macdonald, R.L. (2002). Enhanced neurosteroid potentiation of ternary GABAA receptors containing the δ subunit. J Neurosci. 22, 1541-1549.
241. Woolley CS (2000). Estradiol facilitates kainic acid-induced, but not flurothyl-induced, behavioral seizure activity in adult female rats. Epilepsia 41,510-515.
242. Wright, D.W., Kellermann, A.L., Hertzberg, V.S., Clark, P.L., Frankel, M., Goldstein, F.C., Salomone, J.P., Dent, L.L., Harris, O.A., Ander, D.S., Lowery, D.W., Patel, M.M., Denson, D.D., Gordon, A.B., Wald, M.M., Gupta, S., Hoffman, S.W., and Stein, D. G (2007). ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 49, 391-402.
243. Wu, F.S., Gibbs, T.T., and Farb, D. H (1991). Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol. 40, 333-336.
244. Xiao, G., Wei, J., Yan, W., Wang, W., and Lu, Z (2008). Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 12(2), R61.
245. Yagami, T., Ueda, K., Asakura, K., Hayasaki-Kajiwara, Y., Nakazato, H., Sakaeda, T., Hata, S., Kuroda, T., Takasu, N., and Hori, Y (2002). Group IB secretory phospholipase A2 induces neuronal cell death via apoptosis. J Neurochem 81, 449-461.
246. Zhang, N., Wei, W., Mody, I., and Houser, C.R. (2007). Altered localization of GABAA receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J Neurosci. 27, 7520-7531.